Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy
CAPPRI
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective We studied the performance of a 15-item, health-related quality-of-life polyneuropathy scale in the clinic setting in patients with diabetic distal sensorimotor polyneuropathy (DSPN).
Methods Patients with DSPN from 11 academic sites completed a total of 231 Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) scales during their clinic visits. Conventional and modern psychometric analyses were performed on the completed forms.
Results Conventional and modern analyses generally indicated excellent psychometric properties of the CAPPRI in patients with DSPN. For example, the CAPPRI demonstrated unidimensionality and performed like an interval-level scale.
Conclusion Attributes of the CAPPRI for DSPN include ease of use and interpretation; unidimensionality, allowing scores to be summed; adequate coverage of disease severity; and the scale's ability to address relevant life domains. Furthermore, the CAPPRI is free and in the public domain. The CAPPRI may assist the clinician and patient with DSPN in estimating disease-specific quality of life, especially in terms of pain, sleep, psychological well-being, and everyday function. The CAPPRI may be most useful in the everyday clinical setting but merits further study in this setting, as well as the clinical trial setting.
Glossary
- CAPPRI=
- Chronic Acquired Polyneuropathy Patient-Reported Index;
- CI=
- confidence interval;
- DIF=
- differential item functioning;
- DSPN=
- distal sensorimotor polyneuropathy;
- HRQOL=
- health-related quality of life;
- INCAT=
- Inflammatory Neuropathy Cause and Treatment;
- MNSQ=
- mean square;
- ODSS=
- Overall Disability Sum Score;
- RPCM=
- Rasch partial credit model
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Podcast: NPub.org/wiy6sj
- Received December 22, 2017.
- Accepted in final form March 20, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathiesS.I. van Nes, E.K. Vanhoutte, P.A. van Doorn et al.Neurology, January 24, 2011 -
Articles
Health-related quality-of-life improvements in CIDP with immune globulin IV 10%The ICE StudyI.S.J. Merkies, V. Bril, M. C. Dalakas et al.Neurology, April 13, 2009 -
Articles
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathiesIngemar S. J. Merkies, Paul I. M. Schmitz, Frans G. A. van der Meché et al.Neurology, February 22, 2000 -
Article
Changing outcome in inflammatory neuropathiesRasch–comparative responsivenessThomas H.P. Draak, Els K. Vanhoutte, Sonja I. van Nes et al.Neurology, November 05, 2014